Latest press releases, statements, manifestos, announcements, etc.

Asia: ADB Wraps Up 40th Annual Meeting in Kyoto

KYOTO, JAPAN – The ADB 40th Annual Meeting of the Board of Governors wrapped up today with ADB President Haruhiko Kuroda hailing the event as providing valuable insights into how ADB can evolve with a changing Asia.

?This has been a memorable and successful meeting,? Mr. Kuroda told Governors at the close of the last business session.
(more…)

Continue ReadingAsia: ADB Wraps Up 40th Annual Meeting in Kyoto

Greece: European Journalists Support Greek Media Strike Over ?Scandalous Risk-taking? With Pension Funds

The International Federation of Journalists (IFJ) and its regional European group, the European Federation of Journalists (EFJ), today expressed their full solidarity for journalists and their unions in Greece, who will go on a 24 hours media strike on Tuesday 8th May to protest government mismanagement of their pension and insurance funds.
(more…)

Continue ReadingGreece: European Journalists Support Greek Media Strike Over ?Scandalous Risk-taking? With Pension Funds

EFJ Says New Study Shows EU Needs Better Laws to Protect Investigative Journalism

At a time when the press is increasingly under surveillance and widespread tightening of security and surveillance measures have endangered the ?watchdog? role of journalists, the European Federation of Journalists (EFJ), the regional group of the International Federation of Journalists, welcomes the recently published survey on media access to information published by the Organisation for Security and Cooperation in Europe (OSCE).
(more…)

Continue ReadingEFJ Says New Study Shows EU Needs Better Laws to Protect Investigative Journalism

Oxfam urges cancellation of Pfizer’s patent on hypertension drug

MANILA, Philippines — International agency, Oxfam urges the Intellectual Property Office
(IPO) to cancel the patent of Pfizer on anti-hypertension drug,
Norvasc in the Philippines following the recent decision of the US
Court of Appeals nullifying the patent granted to Pfizer for
amlodipine besylate, Norvasc’s active ingredient.
(more…)

Continue ReadingOxfam urges cancellation of Pfizer’s patent on hypertension drug